U.S. Court in DC Says J&J Needed Agency Approval for 340B Rebate Model
- July 11, 2025
The Health Resources and Services Administration (HRSA) properly concluded that Johnson & Johnson (J&J) needed the agency’s approval before shifting to a rebate model for providing discounts under the 340B drug pricing program, the U.S. District Court for the District of Columbia held June 27.
ARTICLE TAGS
You must be logged in to access this content.